News

Vitamin E is the key: a pharmacist has discovered a substance that ‘switches off’ inflammation

Alzheimer’s, obesity or atherosclerosis: many lifestyle-related diseases are driven by or accompanied by inflammation. “Treatments usually aim to halt the progression of inflammation. However, for a long-term cure, it must be completely resolved,” explains Andreas Koeberle, a pharmacist at the University of Graz. Normally, the body carries out this work itself. However, if this process does not function properly, chronic inflammation can develop, which can contribute to conditions such as cardiovascular disease or cancer.

BioSPM Summer School in Kanazawa, Japan

Taking part in the BioSPM Summer School 2026 at Kanazawa University in Japan will give Dr Ivana Ruseska from the Department of Pharmaceutical Technology and Biopharmacy an insight into modern scanning probe microscopy, in particular HS-AFM, and its applications in biological research.

Visiting Award for High-Potentials 2026

The University of Graz has awarded Dr Ivana Ruseska from the Department of Pharmaceutical Technology & Biopharmacy the “Visiting Award for High Potentials 2026”. This award enables her to undertake an eight-week research visit at the Helmholtz Zentrum München.

19th Pharma DocDay, 2 July 2026

The Doctoral School of Pharmaceutical Sciences at the University of Graz is pleased to announce the 19th Pharma DocDay, taking place on 2 July 2026 at the Institute of Pharmaceutical Sciences.

From High-speed AFM to Nano-Virology

In-depth insights into the world of cutting-edge biophysical research at the 25th Linz Winter School.

Dual role: Researchers show that platelets can worsen disease

Platelets are best known as rapid responders in the event of injury. They stop bleeding and are indispensable for wound healing. “However, thrombocytes can also aggravate diseases, especially when inflammatory processes are involved,” explains Marion Mußbacher, a pharmacist at the University of Graz. She investigated the “dual role” of platelets in relation to fatty liver disease, a condition closely linked to obesity and type 2 diabetes.

Forscher:innen entdecken natürlichen Wirkstoff zum Schutz vor Lebererkrankungen

Die Leber leidet still. „Fetteinlagerungen, strukturelle Zerstörung des Gewebes oder mutierende Tumorzellen – all das fliegt eine Weile unter dem Radar. Begleitet werden diese Veränderungen oft von leichten, jedoch chronischen Entzündungen“, erklärt Andreas Koeberle, Pharmazeut an der Universität Graz. Er hat mit seinem Team und Kolleg:innen der Universität Innsbruck den Wirkstoff Mitrephoron B untersucht, der neue Behandlungsansätze ermöglicht. Die Ergebnisse der Studie wurden kürzlich in der Open-Access-Fachzeitschrift „Theranostics“ veröffentlicht.

Green Academia Award

The Institute of Pharmaceutical Sciences is one of the lucky winners of the Green Academia Award presented by the University of Graz.

More news

18th Pharma Doc Day, 1st of July 2025

Interaktive Lernelemente gestalten

ZDLL Webinar am 20.3.2025

"Being a Scientist"

Workshop in der VS-Waltendorf am 17.03.2025

Drogenanalytik - Was steckt wirklich drin?

Prof. Dr. Martin Schmid im Interview beim ÖAZ-Podcast "ÖAZ im Ohr"

Dem Leberfett zu Leibe gerückt: Solveigh Koeberle forscht an neuen Medikamenten

Zellfunktionen verstehen, um Krankheiten vorbeugen: Das ist die Absicht der Pharmazeutin Solveigh Koeberle. Für ihre Untersuchungen zu Leberfett wird…

Was Krebszellen schwach macht: Neuer Ansatz im Kampf gegen Therapieresistenz

Andreas Koeberle erforscht die Wirkung verschiedener zytotoxischer Naturstoffe auf Krebszellen

EU Project Network Meeting

Biopharmaceutics/Biologics Research Group Visits Leuven for EU Project Network Meeting

Funding of the Elise-Richter project

‘Redox-regenerative agents in ferroptosis’